Five medical device companies that make pelvic mesh implants are hoping to negotiate settlements for the more than 30,000 pending lawsuits they’re facing in the U.S., anonymous sources told Bloomberg.
Cook Medical
Cook Medical lands extra Medicare coverage for Zilver PTX stent
Cook Medical touted new Medicare reimbursement coverage for its Zilver PTX drug-eluting stent, which now qualifies for Medicare’s new-technology add-on payments, according to a company statement. The additional payments are available only for in-patient procedures, not affecting physician or hospital coverage for out-patient procedures or ambulatory surgery center reimbursements.
Cook Medical gets its Zilver PTX back on the market
Three months after the recall of its Zilver PTX peripheral stent, Cook Medical has the device back on the market across the globe.
Rob Lyles, vice president and global leader of Cook’s peripheral intervention business, told MassDevice.com today that the FDA cleared the device to go back on the U.S. market July 25.
Microsoft’s growing app market opens doors for mHealth companies | MassDevice.com On Call
MASSDEVICE ON CALL — AirStrip Technologies CEO Alan Portela said that the mobile patient monitoring software company is taking notice of Microsoft’s new initiative to build its app market for the Surface tablets.
Microsoft’s new design program, called AppsForSurface, is a chance for AirStrip to take its cardiology and obstetrics apps to the mobile Windows world, allowing physicians access on desktops and PCs, the company reported.
Cook Medical lands FDA win for Evolution biliary gastrointestinal stent
Medical device maker Cook Medical won FDA clearance for its Evolution biliary stent, the latest in the company’s line of controlled-release stents designed for use in the gastrointestinal tract.
Like the rest of the Evolution line, the newly cleared biliary stent delivery system includes recapture technology that allows physicians to modify the stent’s placement before full deployment.
Update: Cook Medical recalls Zilver PTX delivery system following patient death
Updated April 25, 2013 with additional comments from Cook Medical.
Cook Medical recalled all sizes, diameters and lot numbers of its Zilver PTX drug-eluting stents after receiving reports of 1 death and 1 patient injury possibly associated with a breakage in the catheter delivery system. It’s not clear when the devices will be back on the market, according to a company spokesman.
Cook Medical’s Zilver Vena venous self-expanding stent trial is a 1st for the U.S.
Indiana medical device giant Cook Medical announced the launch of a new clinical study, the 1st of its kind evaluating the safety and effectiveness of its Zilver Vena venous self-expanding stent.
The VIVO study will enroll select adult patients experiencing limiting leg pain, leg swelling or skin discoloration or a healed or active lower leg ulcer, according to a Cook statement.
Medical device tax: “The straw that broke the camel’s back”
Cook Group chairman Steve Ferguson told Sen. Pat Toomey (R-Pa.) at a House Ways & Means Committee meeting yesterday that the medical device tax is the "straw that broke the camel’s back" in terms of sending medical device manufacturing overseas.
Smartphone-enabled prosthetics keep amputees out of the office | MassDevice.com On Call
MASSDEVICE ON CALL —
GPO: Novation awards new deals to medtech giants
Group purchasing organization Novation awarded new cardiovascular contracts to a host of market leaders, effective at the beginning of 2013.
Endotach sues Medtronic over stent graft patents
Medtronic (NYSE:MDT) infringes a pair of patents licensed to Endotach LLC with 3 of its stent grafts for treating abdominal aortic aneurysms, according to a lawsuit filed by Endotach against the medtech titan.
The Frisco, Texas-based company holds the exclusive license to the duo of patents from their inventor’s widow, according to court documents.